Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,458 | -8,221 | -37,939 | -26,844 | -18,409 |
| Depreciation Amortization | 500 | 251 | 960 | 711 | 466 |
| Accounts payable and accrued liabilities | 11 | 50 | 45 | -127 | 87 |
| Other Working Capital | -1,241 | -1,682 | -525 | -2,122 | -1,064 |
| Other Operating Activity | 16,552 | 1,164 | 3,215 | 1,560 | 906 |
| Operating Cash Flow | $-14,636 | $-8,438 | $-34,244 | $-26,822 | $-18,014 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -7 | -280 | -253 | -150 |
| Investing Cash Flow | $-13 | $-7 | $-280 | $-253 | $-150 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,167 | -1,667 | N/A | N/A | N/A |
| Common Stock Issued | 4,857 | 412 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -121 | 0 | 0 |
| Financing Cash Flow | $690 | $-1,255 | $-121 | $N/A | $N/A |
| Beginning Cash Position | 35,679 | 35,679 | 70,324 | 70,324 | 70,324 |
| End Cash Position | 21,720 | 25,979 | 35,679 | 43,249 | 52,160 |
| Net Cash Flow | $-13,959 | $-9,700 | $-34,645 | $-27,075 | $-18,164 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,636 | -8,438 | -34,244 | -26,822 | -18,014 |
| Capital Expenditure | -13 | -7 | -457 | -410 | -307 |
| Free Cash Flow | -14,649 | -8,445 | -34,701 | -27,232 | -18,321 |